Hamdy Ahmed MD
Insider CIK 1458506 · CRIS CMO · VINC See Remarks, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRIS CURIS INC | C Conversion deriv | 2026-03-20 | 2026-03-23 | 50 | — | $0 | 0 | SEC↗ |
| CRIS CURIS INC | C Conversion | 2026-03-20 | 2026-03-23 | 66,667 | — | $0 | 66,667 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 50 | — | $0 | 50 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2025-05-01 | 2025-05-05 | 200,000 | $2.48 | $496.0K | 200,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | D To issuer deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 0 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2024-08-12 | 2024-08-14 | 90,000 | — | $0 | 90,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | D To issuer deriv | 2024-08-12 | 2024-08-14 | 90,000 | — | $0 | 0 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | D To issuer deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 0 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2024-08-12 | 2024-08-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | D To issuer deriv | 2024-08-12 | 2024-08-14 | 146,746 | — | $0 | 0 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2024-08-12 | 2024-08-14 | 127,500 | — | $0 | 127,500 | SEC↗ |
| VINC Vincerx Pharma, Inc. | D To issuer deriv | 2024-08-12 | 2024-08-14 | 127,500 | — | $0 | 0 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2024-08-12 | 2024-08-14 | 53,254 | — | $0 | 200,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | D To issuer deriv | 2024-08-12 | 2024-08-14 | 53,254 | — | $0 | 0 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2024-08-12 | 2024-08-14 | 146,746 | — | $0 | 146,746 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2024-05-23 | 2024-05-29 | 53,254 | — | $0 | 200,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 146,746 | — | $0 | 146,746 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2023-08-10 | 2023-08-10 | 5,400 | $0.96 | $5.2K | 96,060 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2023-08-09 | 2023-08-10 | 16,900 | $0.95 | $16.1K | 90,660 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2023-02-15 | 2023-02-16 | 90,000 | — | $0 | 90,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2022-12-14 | 2022-12-14 | 35,280 | $0.87 | $30.7K | 73,760 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2022-11-15 | 2022-11-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2022-08-25 | 2022-08-29 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2022-06-23 | 2022-06-27 | 24,200 | $1.41 | $34.1K | 38,480 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2022-02-14 | 2022-02-16 | 127,500 | — | $0 | 127,500 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2021-12-22 | 2021-12-27 | 6,450 | $10.02 | $64.6K | 14,280 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2021-06-29 | 2021-06-30 | 7,830 | $12.77 | $100.0K | 7,830 | SEC↗ |
| VINC Vincera Pharma, Inc. | A Award | 2020-12-23 | 2020-12-28 | 1,618,199 | — | $0 | 1,618,199 | SEC↗ |